Office of the Commissioner of Lobbying of Canada Office of the Commissioner of Lobbying of Canada

Language selection

Registry of Lobbyists

Advanced Registry Search Results

Search Criteria

Share this search Create an alert
Start over
Modify criteria

Refine registrations results by

Status Type Subject matter Government institutions

If you would like to view a summary of the last 12 months for a lobbying activity, use the 12-Month Lobbying Activity Search

Registration (144205)
Results: 1-50 | Export
  1. Michelin North America (Canada) Inc.
    Type: Consultant
    Lobbyist: Philip Cartwright, Global Public Affairs
    Registration: 10 of 10 (2024-05-17 to present)
    Posted: 2024-05-17
    Subject matter details: 1
    Government institutions: 11
    Communication techniques: 2
    Government funding: No
  2. Amex Bank of Canada / Banque Amex du Canada
    Type: In-house Corporation
    Responsible officer: Brett Mooney, President and Chief Executive Officer
    Registration: 35 of 35 (2024-05-17 to present)
    Posted: 2024-05-17
    Subject matter details: 6
    Government institutions: 8
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 15
  3. AMEX Bank of Canada
    Type: Consultant
    Lobbyist: EVAN ZELIKOVITZ, APCO WORLDWIDE (CANADA)
    Registration: 5 of 5 (2024-05-17 to present)
    Posted: 2024-05-17
    Subject matter details: 1
    Government institutions: 5
    Communication techniques: 2
    Government funding: No
  4. Canadian Fuels Association / association canadienne des carburants
    Type: Consultant
    Lobbyist: William Simpkins
    Registration: 8 of 8 (2024-05-17 to present)
    Posted: 2024-05-17
    Subject matter details: 1
    Government institutions: 3
    Communication techniques: 3
    Government funding: No
  5. Canadian Cattle Association / Association canadienne des bovins
    Type: In-house Organization
    Responsible officer: DENNIS LAYCRAFT, EXECUTIVE VICE PRESIDENT
    Registration: 81 of 81 (2024-05-17 to present)
    Posted: 2024-05-17
    Subject matter details: 6
    Government institutions: 34
    Communication techniques: 3
    Government funding: Yes
    Employees who lobby: 8
  6. Cadexair
    Type: In-house Corporation
    Responsible officer: Francis Brassard, CEO, Directeur Général
    Registration: 3 of 3 (2024-05-17 to present)
    Posted: 2024-05-17
    Subject matter details: 2
    Government institutions: 4
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 3
  7. Digital First Canada
    Type: In-house Organization
    Responsible officer: Scott Benzie, Executive Director
    Registration: 4 of 4 (2024-05-17 to present)
    Posted: 2024-05-17
    Subject matter details: 4
    Government institutions: 2
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 1
  8. Vale Canada Ltd.
    Type: Consultant
    Lobbyist: Marie Lemieux, PAA Advisors | Conseils
    Registration: 8 of 8 (2024-05-17 to present)
    Posted: 2024-05-17
    Subject matter details: 1
    Government institutions: 19
    Communication techniques: 3
    Government funding: Yes
  9. Evonik Canada Inc.
    Type: Consultant
    Lobbyist: Alicia Adams, Earnscliffe Strategy Group
    Registration: 3 of 3 (2024-05-17 to present)
    Posted: 2024-05-17
    Subject matter details: 6
    Government institutions: 19
    Communication techniques: 2
    Government funding: No
  10. Dynamit Nobel Defence GmbH
    Type: Consultant
    Lobbyist: Andrew Lutes, Twenty20 Insight Inc.
    Registration: 3 of 3 (2024-05-17 to present)
    Posted: 2024-05-17
    Subject matter details: 1
    Government institutions: 1
    Communication techniques: 2
    Government funding: No
  11. Mitacs Inc.
    Type: In-house Organization
    Responsible officer: John Hepburn, Chief Executive Officer
    Registration: 62 of 62 (2024-05-17 to present)
    Posted: 2024-05-17
    Subject matter details: 3
    Government institutions: 31
    Communication techniques: 2
    Government funding: Yes
    Employees who lobby: 13
  12. SheIS Inc
    Type: Consultant
    Lobbyist: Sonya Moore, Capital Hill Group
    Registration: 4 of 4 (2024-05-17 to present)
    Posted: 2024-05-17
    Subject matter details: 1
    Government institutions: 7
    Communication techniques: 2
    Government funding: No
  13. Ovotech inc.
    Type: Consultant
    Lobbyist: Jonathan Vandal, JV Conseil inc.
    Registration: 3 of 3 (2024-05-17 to present)
    Posted: 2024-05-17
    Subject matter details: 1
    Government institutions: 1
    Communication techniques: 2
    Government funding: No
  14. Nature United
    Type: Consultant
    Lobbyist: Alicia Adams, Earnscliffe Strategy Group
    Registration: 4 of 4 (2024-05-17 to present)
    Posted: 2024-05-17
    Subject matter details: 4
    Government institutions: 16
    Communication techniques: 2
    Government funding: Yes
  15. RaceRocks 3D
    Type: Consultant
    Lobbyist: DAVE HATHERALL, CFN CONSULTANTS
    Registration: 2 of 2 (2024-05-16 to present)
    Posted: 2024-05-16
    Subject matter details: 1
    Government institutions: 12
    Communication techniques: 2
    Government funding: No
  16. RaceRocks 3D
    Type: Consultant
    Lobbyist: PETER STUDER, CFN Consultants
    Registration: 2 of 2 (2024-05-16 to present)
    Posted: 2024-05-16
    Subject matter details: 1
    Government institutions: 12
    Communication techniques: 2
    Government funding: No
  17. 3M Canada Company
    Type: Consultant
    Lobbyist: Laila Hawrylyshyn, Crestview Strategy
    Registration: 1 of 1 (2024-05-16 to present)
    Posted: 2024-05-16
    Subject matter details: 5
    Government institutions: 29
    Communication techniques: 2
    Government funding: Yes
  18. The Canadian Committee for a Sustainable Eel Fishery (CCSEF)
    Type: Consultant
    Lobbyist: PATRICK DION, Patrick Dion Consulting
    Registration: 4 of 4 (2024-05-16 to present)
    Posted: 2024-05-16
    Subject matter details: 1
    Government institutions: 5
    Communication techniques: 2
    Government funding: No
  19. AccertaClaim Servicorp Inc.
    Type: Consultant
    Lobbyist: Derrick Araneda, S&A Strategies
    Registration: 3 of 3 (2024-05-16 to present)
    Posted: 2024-05-16
    Subject matter details: 1
    Government institutions: 1
    Communication techniques: 2
    Government funding: No
  20. Canada's Accredited Zoos and Aquariums / Aquariums et zoos accrédités du Canada
    Type: Consultant
    Lobbyist: DAVID ANGUS, The Capital Hill Group Inc.
    Registration: 2 of 2 (2024-05-16 to present)
    Posted: 2024-05-16
    Subject matter details: 1
    Government institutions: 1
    Communication techniques: 2
    Government funding: No
  21. Canadian Council for the Advancement of Native Development Officers (CANDO)
    Type: Consultant
    Lobbyist: DAVID ANGUS, The Capital Hill Group Inc.
    Registration: 4 of 4 (2024-05-16 to present)
    Posted: 2024-05-16
    Subject matter details: 2
    Government institutions: 14
    Communication techniques: 2
    Government funding: No
  22. Heating, Refrigeration & Air Conditioning Institute of Canada
    Type: Consultant
    Lobbyist: Anastasios Housakos, IMPACT PUBLIC AFFAIRS
    Registration: 3 of 3 (2024-05-16 to present)
    Posted: 2024-05-16
    Subject matter details: 7
    Government institutions: 8
    Communication techniques: 3
    Government funding: No
  23. Airbus Helicopters Canada Limited
    Type: In-house Corporation
    Responsible officer: Dwayne Charette, President and COO
    Registration: 22 of 22 (2024-05-16 to present)
    Posted: 2024-05-17
    Subject matter details: 6
    Government institutions: 23
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 2
  24. Alibaba Group Holding Limited
    Type: Consultant
    Lobbyist: JEFF SMITH, Longview Communications and Public Affairs
    Registration: 2 of 2 (2024-05-16 to present)
    Posted: 2024-05-16
    Subject matter details: 1
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
  25. Public Service Alliance of Canada / Alliance de la Fonction publique du Canada
    Type: In-house Organization
    Responsible officer: Chris Aylward, National President
    Registration: 72 of 72 (2024-05-16 to present)
    Posted: 2024-05-16
    Subject matter details: 15
    Government institutions: 34
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 40
  26. Allied Universal Security Services
    Type: Consultant
    Lobbyist: DAVID ANGUS, The Capital Hill Group Inc.
    Registration: 5 of 5 (2024-05-16 to present)
    Posted: 2024-05-16
    Subject matter details: 1
    Government institutions: 10
    Communication techniques: 2
    Government funding: No
  27. Amazon.com.ca, Inc.
    Type: Consultant
    Lobbyist: Michael McLaren, Thorsteinssons LLP
    Registration: 6 of 6 (2024-05-16 to present)
    Posted: 2024-05-16
    Subject matter details: 1
    Government institutions: 1
    Communication techniques: 2
    Government funding: No
  28. Duty Free Americas, Inc.
    Type: Consultant
    Lobbyist: Philippe Bolduc, Wellington Advocacy Inc.
    Registration: 3 of 3 (2024-05-16 to present)
    Posted: 2024-05-16
    Subject matter details: 1
    Government institutions: 8
    Communication techniques: 2
    Government funding: No
  29. Canadian Shareholder Association for Research and Education
    Type: In-house Organization
    Responsible officer: Kevin Thomas, Chief Executive Officer
    Registration: 8 of 8 (2024-05-16 to present)
    Posted: 2024-05-16
    Subject matter details: 5
    Government institutions: 7
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 3
  30. Bromine Science and Environmental Forum
    Type: Consultant
    Lobbyist: CHRIS BENEDETTI, Sussex Strategy Group
    Registration: 10 of 10 (2024-05-16 to present)
    Posted: 2024-05-16
    Subject matter details: 1
    Government institutions: 6
    Communication techniques: 3
    Government funding: No
  31. Kohl & Frisch
    Type: Consultant
    Lobbyist: Derrick Araneda, S&A Strategies
    Registration: 5 of 5 (2024-05-16 to present)
    Posted: 2024-05-16
    Subject matter details: 2
    Government institutions: 2
    Communication techniques: 2
    Government funding: No
  32. Financial Data And Technology Association
    Type: Consultant
    Lobbyist: Rhys Dumond, Summa Strategies Canada
    Registration: 2 of 2 (2024-05-16 to present)
    Posted: 2024-05-16
    Subject matter details: 1
    Government institutions: 7
    Communication techniques: 2
    Government funding: No
  33. SALVATION ARMY CANADA AND BERMUDA TERRITORY (THE) / Armée du Salut du Canada et des Bermudes
    Type: In-house Organization
    Responsible officer: Lee Graves, Territorial Commander
    Registration: 54 of 54 (2024-05-16 to present)
    Posted: 2024-05-16
    Subject matter details: 7
    Government institutions: 8
    Communication techniques: 2
    Government funding: Yes
    Employees who lobby: 13
  34. Centre for Health Science and Law / Centre pour les Sciences de la Santé et le Droit
    Type: In-house Corporation
    Responsible officer: BILL JEFFERY, Executive Director
    Registration: 14 of 14 (2024-05-16 to present)
    Posted: 2024-05-16
    Subject matter details: 19
    Government institutions: 11
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 1
  35. David Mirvish Gallery Inc. and David Mirvish Gallery Limited
    Type: Consultant
    Lobbyist: Richard Conway, RAC Counsel, Professional Corporation
    Registration: 8 of 8 (2024-05-16 to present)
    Posted: 2024-05-16
    Subject matter details: 1
    Government institutions: 1
    Communication techniques: 2
    Government funding: No
  36. Ant Group Co., Ltd.
    Type: Consultant
    Lobbyist: JEFF SMITH, Longview Communications and Public Affairs
    Registration: 4 of 4 (2024-05-16 to present)
    Posted: 2024-05-16
    Subject matter details: 2
    Government institutions: 8
    Communication techniques: 2
    Government funding: No
  37. Apotex Inc.
    Type: Consultant
    Lobbyist: Alexandra Spence, Loyalist Public Affairs
    Registration: 1 of 1 (2024-05-16 to present)
    Posted: 2024-05-16
    Subject matter details: 1
    Government institutions: 11
    Communication techniques: 2
    Government funding: No
  38. Archer Daniels Midland
    Type: Consultant
    Lobbyist: Martin-Pierre Pelletier, Prospectus Associates
    Registration: 5 of 5 (2024-05-16 to present)
    Posted: 2024-05-16
    Subject matter details: 1
    Government institutions: 6
    Communication techniques: 2
    Government funding: No
  39. NTEA - The Work Truck Association
    Type: Consultant
    Lobbyist: Jeffrey Phillips, Dawson Strategic
    Registration: 13 of 13 (2024-05-16 to present)
    Posted: 2024-05-16
    Subject matter details: 9
    Government institutions: 5
    Communication techniques: 2
    Government funding: No
  40. Canada Organic Trade Association / Association pour le commerce des produits biologiques
    Type: In-house Organization
    Responsible officer: Tia Loftsgard, Executive Director
    Registration: 104 of 104 (2024-05-16 to present)
    Posted: 2024-05-16
    Subject matter details: 6
    Government institutions: 16
    Communication techniques: 3
    Government funding: Yes
    Employees who lobby: 2
  41. MANITOBA INTERNATIONAL PHARMACISTS ASSOCIATION
    Type: Consultant
    Lobbyist: DAVID DYER, THE CAPITAL HILL GROUP INC.
    Registration: 18 of 18 (2024-05-16 to present)
    Posted: 2024-05-16
    Subject matter details: 1
    Government institutions: 5
    Communication techniques: 2
    Government funding: No
  42. Canadian International Pharmacy Association
    Type: Consultant
    Lobbyist: DAVID DYER, THE CAPITAL HILL GROUP
    Registration: 11 of 11 (2024-05-16 to present)
    Posted: 2024-05-16
    Subject matter details: 1
    Government institutions: 4
    Communication techniques: 2
    Government funding: No
  43. Canadian Vehicle Manufacturer's Association / Association canadienne des constructeurs de véhicules
    Type: Consultant
    Lobbyist: Anastasios Housakos, IMPACT PUBLIC AFFAIRS
    Registration: 2 of 2 (2024-05-16 to present)
    Posted: 2024-05-16
    Subject matter details: 1
    Government institutions: 3
    Communication techniques: 3
    Government funding: No
  44. Association des bannières et des chaînes de pharmacies du Québec
    Type: Consultant
    Lobbyist: Hugues Mousseau, Heyco Advisory Services Inc. / Cabinet conseil Heyco inc.
    Registration: 8 of 8 (2024-05-16 to present)
    Posted: 2024-05-16
    Subject matter details: 1
    Government institutions: 1
    Communication techniques: 2
    Government funding: No
  45. Association des bannières et des chaînes de pharmacies du Québec
    Type: Consultant
    Lobbyist: Hugues Mousseau, Heyco Advisory Services Inc. / Cabinet conseil Heyco inc.
    Registration: 7 of 8 (2024-05-16 to 2024-05-16)
    Posted: 2024-05-16
    Subject matter details: 1
    Government institutions: 1
    Communication techniques: 2
    Government funding: No
  46. Helium Developers Association of Canada
    Type: Consultant
    Lobbyist: Richard Dunn, Capilano Policy Group
    Registration: 3 of 3 (2024-05-16 to present)
    Posted: 2024-05-16
    Subject matter details: 1
    Government institutions: 8
    Communication techniques: 2
    Government funding: No
  47. Canadian Public Works Association / Association Canadienne des Travaux Publics
    Type: Consultant
    Lobbyist: Philip Baldwin, TACTIX Government Relations & Public Affairs Inc.
    Registration: 4 of 4 (2024-05-16 to present)
    Posted: 2024-05-16
    Subject matter details: 2
    Government institutions: 12
    Communication techniques: 3
    Government funding: No
  48. Canadian Automobile Dealers Association (CADA) / Corporation des associations de détaillants d'automobiles (CADA)
    Type: Consultant
    Lobbyist: Rachel Loif, Impact Public Affairs
    Registration: 1 of 1 (2024-05-16 to present)
    Posted: 2024-05-16
    Subject matter details: 12
    Government institutions: 13
    Communication techniques: 3
    Government funding: No
  49. Canadian Automobile Dealers Association (CADA) / Corporation des associations de détaillants d'automobiles (CADA)
    Type: Consultant
    Lobbyist: Daniel Marino, IMPACT PUBLIC AFFAIRS
    Registration: 1 of 1 (2024-05-16 to present)
    Posted: 2024-05-17
    Subject matter details: 12
    Government institutions: 13
    Communication techniques: 3
    Government funding: No
  50. VIH Aviation Group
    Type: Consultant
    Lobbyist: DAVID ANGUS, The Capital Hill Group Inc.
    Registration: 11 of 11 (2024-05-16 to present)
    Posted: 2024-05-16
    Subject matter details: 1
    Government institutions: 15
    Communication techniques: 2
    Government funding: No
Monthly communication reports (87)
Results: 1-50 | Export
  1. Québec Association of Pharmacy Distributors / Association québécoise des distributeurs en pharmacie
    Type: Consultant
    Lobbyist: Hugues Mousseau, Heyco Advisory Services Inc. / Cabinet conseil Heyco inc.
    Occurred: 2023-12-06
    Posted: 2023-12-08
    Designated public office holders:
    • Thomas Digby, Président, Conseil | Patented Medicine Prices Review Board (PMPRB)
    • Anie Perrault, Vice-présidente du Conseil, Conseil | Patented Medicine Prices Review Board (PMPRB)
    • Carolyn Kobernick, Membre du Conseil, Conseil | Patented Medicine Prices Review Board (PMPRB)
    • Guillaume Couillard, Directeur exécutif par intérim, Conseil | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
      •
  2. RAREi - The Canadian Forum for Rare Disease Innovators / iRARE, le Forum canadien des innovateurs spécialisés dans les maladies rares
    Type: Consultant
    Lobbyist: WILLIAM DEMPSTER, 3Sixty Public Affairs Inc.
    Occurred: 2023-10-06
    Posted: 2023-11-15
    Designated public office holders:
    • Guillaume Couillard, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
      •
  3. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-07-21
    Posted: 2023-08-01
    Designated public office holders:
    • Thomas Digby, Chairperson | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
    • Industry
    • Intellectual Property
      •
  4. IQVIA Solutions Canada Inc.
    Type: In-house Corporation
    Occurred: 2023-05-17
    Posted: 2023-05-18
    Designated public office holders:
    • Thomas Digby, Chairperson to the Patented Medicine Prices Review Board (PMPRB) | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
      •
  5. RAREi - The Canadian Forum for Rare Disease Innovators / iRARE, le Forum canadien des innovateurs spécialisés dans les maladies rares
    Type: Consultant
    Lobbyist: WILLIAM DEMPSTER, 3Sixty Public Affairs Inc.
    Occurred: 2022-12-05
    Posted: 2023-01-16
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • International Trade
    • Industry
    • Economic Development
    • Taxation and Finance
    • Health
    • Science and Technology
    • Intellectual Property
      •
  6. RAREi - The Canadian Forum for Rare Disease Innovators / iRARE, le Forum canadien des innovateurs spécialisés dans les maladies rares
    Type: Consultant
    Lobbyist: GERALD JEFFCOTT, 3Sixty Public Affairs
    Occurred: 2022-12-05
    Posted: 2022-12-09
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
      •
  7. Hoffmann-La Roche Limited
    Type: In-house Corporation
    Occurred: 2022-11-29
    Posted: 2022-12-13
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
      •
  8. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-10-27
    Posted: 2022-11-15
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
      •
  9. Sun Life Financial Inc. / Financière Sun Life
    Type: In-house Corporation
    Occurred: 2022-10-19
    Posted: 2022-11-14
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
      •
  10. RAREi - The Canadian Forum for Rare Disease Innovators / iRARE, le Forum canadien des innovateurs spécialisés dans les maladies rares
    Type: Consultant
    Lobbyist: WILLIAM DEMPSTER, 3Sixty Public Affairs Inc.
    Occurred: 2022-07-07
    Posted: 2022-08-15
    Designated public office holders:
    • Tanya Potashnik , Director of Policy and Economic Analysis | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • International Trade
    • Taxation and Finance
    • Intellectual Property
    • Science and Technology
    • Economic Development
    • Health
    • Industry
      •
  11. RAREi - The Canadian Forum for Rare Disease Innovators / iRARE, le Forum canadien des innovateurs spécialisés dans les maladies rares
    Type: Consultant
    Lobbyist: GERALD JEFFCOTT, 3Sixty Public Affairs
    Occurred: 2022-07-07
    Posted: 2022-08-04
    Designated public office holders:
    • Tanya Potashnik, Director of Policy and Economic Analysis | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
      •
  12. Sun Life Financial Inc. / Financière Sun Life
    Type: In-house Corporation
    Occurred: 2022-06-10
    Posted: 2022-07-11
    Designated public office holders:
    • Douglas Clark , Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
      •
  13. The Canada Life Assurance Company / de la Compagnie d'Assurance du Canada sur la Vie
    Type: In-house Corporation
    Occurred: 2022-06-07
    Posted: 2022-07-15
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
      •
  14. GlaxoSmithKline
    Type: In-house Corporation
    Occurred: 2022-06-01
    Posted: 2022-06-30
    Designated public office holders:
    • Douglas Clark , Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
      •
  15. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-05-24
    Posted: 2022-06-15
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
      •
  16. AbbVie Corporation
    Type: In-house Corporation
    Occurred: 2022-04-14
    Posted: 2022-04-29
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Industry
      •
  17. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-04-07
    Posted: 2022-05-16
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
      •
  18. Takeda Canada Inc.
    Type: Consultant
    Lobbyist: Ian Chesney, Santis Health
    Occurred: 2020-12-14
    Posted: 2020-12-14
    Designated public office holders:
    • Doug Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
    • Science and Technology
    • Economic Development
    • Research and Development
      •
  19. Sunovion Pharmaceuticals Canada Inc.
    Type: Consultant
    Lobbyist: Kate Dalgleish, Compass Rose Group
    Occurred: 2020-12-09
    Posted: 2021-01-15
    Designated public office holders:
    • Elena Lungu, Manager, Policy Development | Patented Medicine Prices Review Board (PMPRB)
    • Isabel Jaen Raasch, General Counsel | Patented Medicine Prices Review Board (PMPRB)
    • Tanya Potashnik, Director, Policy & Economic Analysis Branch | Patented Medicine Prices Review Board (PMPRB)
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Research and Development
    • Health
      •
  20. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2020-10-22
    Posted: 2020-11-16
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
      •
  21. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2020-10-07
    Posted: 2020-11-16
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
      •
  22. Vertex Pharmaceuticals (Canada) Incorporated
    Type: In-house Corporation
    Occurred: 2020-08-12
    Posted: 2020-09-09
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Intellectual Property
    • Health
      •
  23. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2020-06-05
    Posted: 2020-07-14
    Designated public office holders:
    • Doug Clark, Executive Director, PMPRB | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
      •
  24. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2020-05-15
    Posted: 2020-06-15
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Research and Development
    • Health
      •
  25. Diabetes Canada / Diabète Canada
    Type: In-house Organization
    Occurred: 2020-01-22
    Posted: 2020-02-15
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
      •
  26. CANADIAN CANCER SOCIETY / Société canadienne du cancer
    Type: In-house Organization
    Occurred: 2019-12-10
    Posted: 2020-01-15
    Designated public office holders:
    • Douglas Clark, Executive Director, Exective Director's office | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
      •
  27. Takeda Canada Inc.
    Type: Consultant
    Lobbyist: Ian Chesney, Santis Health
    Occurred: 2019-07-29
    Posted: 2019-07-29
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
    • Science and Technology
    • Research and Development
    • Budget
    • Economic Development
      •
  28. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2019-05-29
    Posted: 2019-06-11
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
    • Industry
      •
  29. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2019-03-07
    Posted: 2019-03-18
    Designated public office holders:
    • Douglas Clark, Executive Director, PMPRB | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
    • Research and Development
    • Industry
      •
  30. Novo Nordisk Canada Inc.
    Type: In-house Organization
    Occurred: 2018-12-11
    Posted: 2018-12-17
    Designated public office holders:
    • Doug Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    • Tanya Potashnick, Director | Patented Medicine Prices Review Board (PMPRB)
    • Matthew Kellison, Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
    • Industry
      •
  31. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2018-12-04
    Posted: 2019-01-13
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
    • Economic Development
      •
  32. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2018-10-25
    Posted: 2018-11-01
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
    • Industry
      •
  33. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2018-09-11
    Posted: 2018-09-28
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Industry
    • Health
      •
  34. GlaxoSmithKline
    Type: In-house Corporation
    Occurred: 2018-06-28
    Posted: 2018-07-05
    Designated public office holders:
    • Doug Clark, Executive Director, PMPRB | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Science and Technology
    • Health
    • Research and Development
    • Economic Development
      •
  35. Novo Nordisk Canada Inc.
    Type: In-house Organization
    Occurred: 2018-05-08
    Posted: 2018-09-07
    Designated public office holders:
    • Douglas Clark, Executive Director, PMPRB | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
    • Economic Development
    • Research and Development
    • Intellectual Property
      •
  36. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2018-04-10
    Posted: 2018-04-12
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
    • Industry
      •
  37. BIOTECANADA
    Type: In-house Organization
    Occurred: 2018-04-09
    Posted: 2018-05-23
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
      •
  38. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2018-03-07
    Posted: 2018-03-16
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
      •
  39. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Occurred: 2017-10-12
    Posted: 2017-11-15
    Designated public office holders:
    • Anju Dhillon, Member of Parliament - Dorval-Lachine-Lasalee | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Intellectual Property
    • Science and Technology
    • Industry
    • Research and Development
    • Health
      •
  40. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2017-10-10
    Posted: 2017-10-23
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
    • Industry
      •
  41. Hoffmann-La Roche Limited
    Type: In-house Corporation
    Occurred: 2017-07-26
    Posted: 2017-08-10
    Designated public office holders:
    • Douglas Clark, Executive Director, Patented Medicines Prices Review Board | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
      •
  42. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2017-05-23
    Posted: 2017-05-23
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Economic Development
    • Research and Development
    • Industry
    • Intellectual Property
    • International Trade
    • Health
      •
  43. Amgen Canada Inc.
    Type: In-house Corporation
    Occurred: 2017-02-13
    Posted: 2017-03-15
    Designated public office holders:
    • Douglas Clark, Director General | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Intellectual Property
    • Health
      •
  44. Bausch Health, Canada Inc. / Bausch Health, Canada Inc. Solutions de Sante
    Type: In-house Organization
    Occurred: 2016-11-22
    Posted: 2016-11-24
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
      •
  45. Canadian Generic Pharmaceutical Association (CGPA) / L'Association canadienne du médicament générique (ACMG)
    Type: In-house Organization
    Occurred: 2016-10-12
    Posted: 2016-11-15
    Designated public office holders:
    • Doug Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Industry
    • Intellectual Property
      •
  46. Apotex Inc.
    Type: In-house Corporation
    Occurred: 2016-10-12
    Posted: 2016-11-21
    Designated public office holders:
    • Doug Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Intellectual Property
    • Industry
      •
  47. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Occurred: 2016-10-12
    Posted: 2016-11-15
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Industry
    • Intellectual Property
      •
  48. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2016-10-11
    Posted: 2016-11-14
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Industry
    • Research and Development
    • Health
    • Intellectual Property
    • Economic Development
      •
  49. GlaxoSmithKline
    Type: In-house Corporation
    Occurred: 2016-07-14
    Posted: 2016-08-15
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
    • Research and Development
    • Intellectual Property
    • Consumer Issues
      •
  50. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Occurred: 2016-06-07
    Posted: 2016-07-15
    Designated public office holders:
    • Jarrett Todd, Regulatory Officer | Patented Medicine Prices Review Board (PMPRB)
    • Ginette Tognet, Director, Regulatory Affairs & Outreach | Patented Medicine Prices Review Board (PMPRB)
    • Isabel Jaen Raasch, General Counsel | Patented Medicine Prices Review Board (PMPRB)
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
    • Industry
      •
Date Modified: